A Repurposing Approach for Uncovering the Anti-Tubercular Activity of FDA-Approved Drugs with Potential Multi-Targeting ProfilesBasem Battah, Sandra Gemma, Giulia Chemi et al.|Molecules|2019Cited by 54
Combined use of Quantiferon and HBHA-based IGRA supports tuberculosis diagnosis and therapy management in childrenMichela Sali, Giovanni Delogu, Danilo Buonsenso et al.|Journal of Infection|2018Cited by 43
3-(Benzodioxan-2-ylmethoxy)-2,6-difluorobenzamides bearing hydrophobic substituents at the 7-position of the benzodioxane nucleus potently inhibit methicillin-resistant Sa and Mtb cell divisionValentina Straniero, Ermanno Valoti, Marco Pallavicini et al.|European Journal of Medicinal Chemistry|2016Cited by 32
Lack of Response to <scp>HBHA</scp> in <scp>HIV</scp>‐Infected Patients with Latent Tuberculosis InfectionGiovanni Delogu, Delia Goletti, Valentina Vanini et al.|Scandinavian Journal of Immunology|2016Cited by 27
PE_PGRS3 of<i>Mycobacterium tuberculosis</i>is specifically expressed at low phosphate concentration, and its arginine-rich C-terminal domain mediates adhesion and persistence in host tissues when expressed in<i>Mycobacterium smegmatis</i>Flavio De Maio, Giovanni Delogu, Basem Battah et al.|Cellular Microbiology|2018Cited by 25